학술논문
Interim safety analysis of nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecular-selected patients (pts) with metastastic castration-resistant prostate cancer (mCRPC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041